1. Home
  2. DCOM vs PCRX Comparison

DCOM vs PCRX Comparison

Compare DCOM & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dime Community Bancshares Inc.

DCOM

Dime Community Bancshares Inc.

HOLD

Current Price

$29.10

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$24.09

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCOM
PCRX
Founded
1864
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
DCOM
PCRX
Price
$29.10
$24.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$34.17
$33.83
AVG Volume (30 Days)
265.7K
736.4K
Earning Date
01-22-2026
11-06-2025
Dividend Yield
3.41%
N/A
EPS Growth
N/A
N/A
EPS
1.18
0.47
Revenue
$340,529,000.00
$716,791,000.00
Revenue This Year
$52.73
$7.27
Revenue Next Year
$16.33
$10.18
P/E Ratio
$24.90
$51.07
Revenue Growth
8.54
3.14
52 Week Low
$23.25
$16.41
52 Week High
$37.13
$27.64

Technical Indicators

Market Signals
Indicator
DCOM
PCRX
Relative Strength Index (RSI) 62.64 57.12
Support Level $27.81 $23.29
Resistance Level $29.06 $24.50
Average True Range (ATR) 1.04 1.00
MACD 0.38 0.08
Stochastic Oscillator 94.66 67.67

Price Performance

Historical Comparison
DCOM
PCRX

About DCOM Dime Community Bancshares Inc.

Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: